ジストニア(Dystonia):世界の治験レビュー(2015年上半期版)

【英語タイトル】Dystonia Global Clinical Trials Review, H1, 2015

GlobalDataが出版した調査資料(GDHC2619CTIDB)・商品コード:GDHC2619CTIDB
・発行会社(調査会社):GlobalData
・発行日:2015年3月27日
・ページ数:90
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界におけるジストニア(Dystonia) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - ジストニア(Dystonia)
  - 当レポートの概要
・ジストニア(Dystonia):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Dystonia Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Dystonia Global Clinical Trials Review, H1, 2015″ provides data on the Dystonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dystonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dystonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Dystonia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Dystonia to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Dystonia to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Dystonia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Dystonia Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Ipsen S.A. 32
Clinical Trial Overview of Ipsen S.A. 32
Actavis plc 33
Clinical Trial Overview of Actavis plc 33
Merz Pharma GmbH & Co. KgaA 34
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 34
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
Solstice Neurosciences, Inc. 36
Clinical Trial Overview of Solstice Neurosciences, Inc. 36
Addex Therapeutics Ltd 37
Clinical Trial Overview of Addex Therapeutics Ltd 37
Flex Pharma, Inc. 38
Clinical Trial Overview of Flex Pharma, Inc. 38
Ethicon, Inc. 39
Clinical Trial Overview of Ethicon, Inc. 39
Biocodex 40
Clinical Trial Overview of Biocodex 40
ASIS Corporation 41
Clinical Trial Overview of ASIS Corporation 41
Clinical Trial Overview of Top Institutes / Government 42
National Institute of Neurological Disorders and Stroke 42
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 42
Leiden University Medical Center 43
Clinical Trial Overview of Leiden University Medical Center 43
University of Florida 44
Clinical Trial Overview of University of Florida 44
Seoul National University Hospital 45
Clinical Trial Overview of Seoul National University Hospital 45
University Health Network 46
Clinical Trial Overview of University Health Network 46
University of South Florida 47
Clinical Trial Overview of University of South Florida 47
Vanderbilt University 48
Clinical Trial Overview of Vanderbilt University 48
Academic Medical Center 49
Clinical Trial Overview of Academic Medical Center 49
Agostino Gemelli University Polyclinic 50
Clinical Trial Overview of Agostino Gemelli University Polyclinic 50
Assistance Publique – Hopitaux de Paris 51
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 51
Five Key Clinical Profiles 52
Appendix 88
Abbreviations 88
Definitions 88
Research Methodology 89
Secondary Research 89
About GlobalData 90
Contact Us 90
Disclaimer 90
Source 90

List of Tables
Dystonia Therapeutics, Global, Clinical Trials by Region, 2015* 7
Dystonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Dystonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Dystonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Dystonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Dystonia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Dystonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Dystonia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Dystonia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Dystonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Dystonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Dystonia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Dystonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Dystonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Dystonia Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Dystonia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Dystonia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Dystonia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Dystonia Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Dystonia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Dystonia Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Dystonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Dystonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Dystonia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Dystonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Dystonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015* 32
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 33
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2015* 34
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 35
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Solstice Neurosciences, Inc., 2015* 36
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Addex Therapeutics Ltd, 2015* 37
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Flex Pharma, Inc., 2015* 38
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ethicon, Inc., 2015* 39
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Biocodex, 2015* 40
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by ASIS Corporation, 2015* 41
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2015* 42
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 43
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 44
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 45
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 46
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2015* 47
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 48
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 49
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Agostino Gemelli University Polyclinic, 2015* 50
Dystonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 51

List of Figures
Dystonia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Dystonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Dystonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Dystonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Dystonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Dystonia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Dystonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Dystonia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Dystonia to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Dystonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Dystonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Dystonia to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Dystonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Dystonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Dystonia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Dystonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Dystonia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Dystonia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Dystonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Dystonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Dystonia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Dystonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Dystonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 89

【レポートのキーワード】

ジストニア(Dystonia)、治験、臨床試験、治験、治療薬

★調査レポート[ジストニア(Dystonia):世界の治験レビュー(2015年上半期版)] (コード:GDHC2619CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[ジストニア(Dystonia):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆